Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 109

1.

Advances in HDL: Much More than Lipid Transporters.

Ben-Aicha S, Badimon L, Vilahur G.

Int J Mol Sci. 2020 Jan 22;21(3). pii: E732. doi: 10.3390/ijms21030732. Review.

2.

CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions.

Rossello X, Rodriguez-Sinovas A, Vilahur G, Crisóstomo V, Jorge I, Zaragoza C, Zamorano JL, Bermejo J, Ordoñez A, Boscá L, Vázquez J, Badimón L, Sánchez-Margallo FM, Fernández-Avilés F, Garcia-Dorado D, Ibanez B.

Sci Rep. 2019 Dec 30;9(1):20290. doi: 10.1038/s41598-019-56613-6.

3.

Molecular pathways involved in the cardioprotective effects of intravenous statin administration during ischemia.

Mendieta G, Ben-Aicha S, Casani L, Badimon L, Sabate M, Vilahur G.

Basic Res Cardiol. 2019 Nov 28;115(1):2. doi: 10.1007/s00395-019-0760-z.

PMID:
31781960
4.

Hyperlipidaemia and cardioprotection: Animal models for translational studies.

Andreadou I, Schulz R, Badimon L, Adameová A, Kleinbongard P, Lecour S, Nikolaou PE, Falcão-Pires I, Vilahur G, Woudberg N, Heusch G, Ferdinandy P.

Br J Pharmacol. 2019 Nov 26. doi: 10.1111/bph.14931. [Epub ahead of print] Review.

PMID:
31769007
5.

Liquid Biopsies: Microvesicles in Cardiovascular Disease.

Badimon L, Suades R, Vilella-Figuerola A, Crespo J, Vilahur G, Escate R, Padro T, Chiva-Blanch G.

Antioxid Redox Signal. 2019 Dec 17. doi: 10.1089/ars.2019.7922. [Epub ahead of print]

PMID:
31696726
6.

HDL remodelled in hypercholesterolemic blood induce epigenetically driven downregulation of endothelial HIF-1α expression in a preclinical animal model.

Ben-Aicha S, Escate R, Casaní L, Padró T, Peña E, Arderiu G, Mendieta G, Badimón L, Vilahur G.

Cardiovasc Res. 2019 Aug 30. pii: cvz239. doi: 10.1093/cvr/cvz239. [Epub ahead of print]

PMID:
31504272
7.

Intravenous Statin Administration During Ischemia Exerts Cardioprotective Effects.

Mendieta G, Ben-Aicha S, Casani L, Badimon L, Sabaté M, Vilahur G.

J Am Coll Cardiol. 2019 Jul 23;74(3):475-477. doi: 10.1016/j.jacc.2019.05.020. No abstract available.

PMID:
31319923
8.

Osteoporosis and vascular calcification: A shared scenario.

García-Gómez MC, Vilahur G.

Clin Investig Arterioscler. 2020 Jan - Feb;32(1):33-42. doi: 10.1016/j.arteri.2019.03.008. Epub 2019 Jun 17. Review. English, Spanish.

PMID:
31221532
9.

MicroRNA-145 Regulates the Differentiation of Adipose Stem Cells Toward Microvascular Endothelial Cells and Promotes Angiogenesis.

Arderiu G, Peña E, Aledo R, Juan-Babot O, Crespo J, Vilahur G, Oñate B, Moscatiello F, Badimon L.

Circ Res. 2019 Jun 21;125(1):74-89. doi: 10.1161/CIRCRESAHA.118.314290. Epub 2019 May 6.

PMID:
31219744
10.

Post-Genomic Methodologies and Preclinical Animal Models: Chances for the Translation of Cardioprotection to the Clinic.

Badimon L, Mendieta G, Ben-Aicha S, Vilahur G.

Int J Mol Sci. 2019 Jan 25;20(3). pii: E514. doi: 10.3390/ijms20030514. Review.

11.

Moderate Beer Intake and Cardiovascular Health in Overweight Individuals.

Padro T, Muñoz-García N, Vilahur G, Chagas P, Deyà A, Antonijoan RM, Badimon L.

Nutrients. 2018 Sep 5;10(9). pii: E1237. doi: 10.3390/nu10091237.

12.

Intracellular platelet signalling as a target for drug development.

Vilahur G, Gutiérrez M, Arzanauskaite M, Mendieta G, Ben-Aicha S, Badimon L.

Vascul Pharmacol. 2018 Dec;111:22-25. doi: 10.1016/j.vph.2018.08.007. Epub 2018 Aug 18. Review.

PMID:
30125683
13.

P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs.

Vilahur G, Gutiérrez M, Casani L, Lambert C, Mendieta G, Ben-Aicha S, Capdevila A, Pons-Lladó G, Carreras F, Carlsson L, Hidalgo A, Badimon L.

Cardiovasc Res. 2018 Dec 1;114(14):1860-1870. doi: 10.1093/cvr/cvy201.

PMID:
30124783
14.

Red Blood Cells Deserve Attention in Patients With Type 2 Diabetes.

Vilahur G.

J Am Coll Cardiol. 2018 Aug 14;72(7):781-783. doi: 10.1016/j.jacc.2018.05.053. No abstract available.

15.

Reply to the letter by Dr. Ulas to the manuscript entitled: "Silybum marianum provides cardioprotection and limits adverse remodeling post-myocardial infarction by mitigating oxidative stress and reactive fibrosis".

Vilahur G, Casaní L, Peña E, Crespo J, Juan-Babot O, Ben-Aicha S, Mendieta G, Béjar MT, Borrell-Pagès M, Badimon L.

Int J Cardiol. 2018 Nov 1;270:78. doi: 10.1016/j.ijcard.2018.07.056. Epub 2018 Jul 18. No abstract available.

PMID:
30031622
16.

Dyslipidemias and Microcirculation.

Padró T, Vilahur G, Badimon L.

Curr Pharm Des. 2018;24(25):2921-2926. doi: 10.2174/1381612824666180702154129. Review.

PMID:
29968532
17.

Silybum marianum provides cardioprotection and limits adverse remodeling post-myocardial infarction by mitigating oxidative stress and reactive fibrosis.

Vilahur G, Casaní L, Peña E, Crespo J, Juan-Babot O, Ben-Aicha S, Mendieta G, Béjar MT, Borrell M, Badimon L.

Int J Cardiol. 2018 Nov 1;270:28-35. doi: 10.1016/j.ijcard.2018.06.030. Epub 2018 Jun 11.

PMID:
29936043
18.

Phytosterols and Inflammation.

Vilahur G, Ben-Aicha S, Diaz-Riera E, Badimon L, Padró T.

Curr Med Chem. 2019;26(37):6724-6734. doi: 10.2174/0929867325666180622151438.

PMID:
29932029
19.

C-Reactive Protein in Atherothrombosis and Angiogenesis.

Badimon L, Peña E, Arderiu G, Padró T, Slevin M, Vilahur G, Chiva-Blanch G.

Front Immunol. 2018 Mar 2;9:430. doi: 10.3389/fimmu.2018.00430. eCollection 2018. Review.

20.

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis.

Rocca B, Fox KAA, Ajjan RA, Andreotti F, Baigent C, Collet JP, Grove EL, Halvorsen S, Huber K, Morais J, Patrono C, Rubboli A, Seljeflot I, Sibbing D, Siegbahn A, Ten Berg J, Vilahur G, Verheugt FWA, Wallentin L, Weiss TW, Wojta J, Storey RF.

Eur Heart J. 2018 May 14;39(19):1672-1686f. doi: 10.1093/eurheartj/ehy066. No abstract available.

PMID:
29509886

Supplemental Content

Loading ...
Support Center